We observed more potential ligand-receptor interactions between TAMs and CD8 + T cells than between cancer cells and CD8 + T cells in both our samples (Fig. 7E; Supplimentary Fig. 7M, N) and the confirmatory dataset (Supplimentary Fig. 7O–P). Here, CD8A is linked to cancer.